Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACT Pilot Study
NCT04949516Phase 4Completed
- Sponsor
- Wonkwang University Hospital
- Start
- Jun 2021
- Primary completion
- Dec 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colchicine in acute coronary syndrome (ACS), sponsored by Wonkwang University Hospital. Primary endpoint: Definite, probable, and possible stent thrombosis (Academic Research Consortium) at 90 days. Started Jun 2021; status: completed.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04949516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04949516.